Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

Marij J. Welters, Tetje C. van der Sluis, Helene van Meir, Nikki M. Loof, Vanessa J. van Ham, Suzanne van Duikeren, Saskia J. Santegoets, Ramon Arens, Marieke L. de Kam, Adam F. Cohen, Mariette I. van Poelgeest, Gemma G. Kenter, Judith R. Kroep, Jacobus Burggraaf, Cornelis J. Melief, Sjoerd H. van der Burg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalScience Translational Medicine
Volume8
Issue number334
DOIs
Publication statusPublished - 13 Apr 2016

Cite this

Welters, M. J., van der Sluis, T. C., van Meir, H., Loof, N. M., van Ham, V. J., van Duikeren, S., ... van der Burg, S. H. (2016). Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses. Science Translational Medicine, 8(334). https://doi.org/10.1126/scitranslmed.aad8307